Minister part of local vaccine trial gets virus

Share

The Health Minister of Haryana, Anil Vij was a part of the Covaxin trials. "It is only 14 days when I got the first shot", Vij tweeted in Hindi.

Britain gave emergency use approval for the vaccine developed by Pfizer and BioNTech last week - jumping ahead in the global race to begin the most crucial mass inoculation programme in history.

Senior sources say both the 94-year-old Monarch and Prince Philip, 99, will not get preferential treatment, but will instead "wait in line" during the first wave of injections reserved for the over-80s and care home residents.

"Vaccines do not equal zero COVID", said WHO Emergencies Director Michael Ryan, adding that not everyone will be able to receive it early next year. But recently he tested positive for coronavirus even after getting a shot of the vaccination.

Millions of doses of a COVID-19 vaccine could be airlifted to Britain if ports are snarled up because Britain fails to agree a trade deal with the European Union when the Brexit transition period ends, a junior foreign office minister said on Monday.

Google brings Pixel 5 features to older Pixel phones
It is an augmented reality app for the 5G Google Pixel devices, available on the Google Play Store right now. Extreme Battery Saver "only runs the essentials so your battery lasts as long as possible".

"Before administering Covaxin, doctors told me that antibodies will develop after 14 days of the second dose".

The authority has prepared a storage warehouse with cold chain management for 1.2 million doses of the COVID-19 vaccine received from China's Sinovac Biotech Ltd before being distributed to health offices nationwide. The minister urged all those who had come in close contact with him to get themselves tested.

According to Bharat Biotech, in the third phase of the vaccine, only 50 percent of the people are given the vaccine while the other 50 percent are given placebo.

Covaxin is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Serum's application stated that data from four clinical studies, two in the United Kingdom and one each in Brazil and India, showed that the vaccine, Covishield, was highly effective against severe COVID-19 infections, the report said. He had offered to be the first volunteer in the phase three trials for Covaxin, an indigenous potential vaccine and was administered the dose on November 20 at the Civil Hospital in Ambala Cantonment, about 50 km from Chandigarh. The vaccine still needs to be evaluated by the country's food and drug agency (BPOM) while his administration prepares to distribute it across the vast archipelago of 270 million people, Jokowi said.

Share